Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation

Status:
Terminated

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

12 Week Efficacy and Safety Trial Followed by a 4 Week Withdrawal Period for Patients with Chronic Idiopathic Constipation.

Phase 3

Ferring Pharmaceuticals